Five companies account for 76.1% of the 340B contract pharmacy market, according to Drug Channels.  Since Congress established the 340B program in ...

A recent report from the Congressional Budget Office found no evidence that savings from the 340B program are passed on to patients. Instead, the program may be encouraging behaviors that increase ...

A new pilot program from the federal government has hospital and pharmacy leaders bracing for what they describe as a fundamental dismantling of the ...

The Kansas Legislature is currently considering a bill, SB 284, under seemingly noble pretense. Proponents of SB 284 argue ...

In 2022, tax-exempt hospitals participating in the 340B Drug Pricing Program provided nearly $100 billion in total benefits to their communities, according to a new AHA report.

When the 340B drug pricing program was established in 1992, Congress intended for the program to help low-income and uninsured patients with their prescription drugs. The pharmaceutical companies ...

AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.

Drugmaker Johnson and Johnson is suing the Department of Health and Human Services and the Health Resources and Services Administration for blocking its new 340B rebate model, and is seeking to verify ...

Legislation that could change the 340B program should be done so with caution, as the federal program acts as a boon to care for patients with HIV, experts argue. The 340B Drug Pricing Program was ...

On Wednesday, health care providers and drug manufacturers hotly debated legislation looking to ensure hospitals can purchase drugs at a reduced price as part of a federal program intended to support ...